8-K: Inspire Veterinary Partners Faces Nasdaq Delisting

Inspire Veterinary Partners, Inc. received a Nasdaq notice for non-compliance with minimum bid price, facing delisting without an appeal.

Summary

• Inspire Veterinary Partners, Inc. (IVP) received a notice from Nasdaq on November 13, 2025, regarding non-compliance with the minimum bid price requirement.
• The company's common stock closing bid price for the prior 30 consecutive business days was below the Nasdaq Listing Rule 5550(a)(2) minimum.
• IVP is not eligible for a compliance period due to having effected reverse stock splits with a cumulative ratio of 250 shares or more to one over the prior one-year and two-year periods.
• Nasdaq intends to suspend trading of IVP's securities on November 24, 2025, and delist them, unless the company appeals.
• IVP plans to request a hearing by November 20, 2025, which will stay the delisting action pending the hearing's conclusion.
• There is no assurance that the appeal will be successful or that the company will regain and maintain Nasdaq listing.

Sentiment

Score: 2

Explanation: The filing indicates a severe negative event for the company, facing imminent delisting from Nasdaq due to non-compliance and ineligibility for a compliance period. While an appeal is planned, the outcome is uncertain, posing significant risks to shareholders.

Positives

• The company intends to request a hearing, which will temporarily stay the delisting process.

Negatives

• Received a notice of non-compliance with Nasdaq's minimum bid price requirement (Rule 5550(a)(2)).
• Ineligible for a compliance period due to multiple reverse stock splits (cumulative ratio of 250:1 or more) over the past two years.
• Faces potential suspension of trading and delisting from The Nasdaq Capital Market starting November 24, 2025.
• No assurance that the appeal to Nasdaq's Hearings Panel will be granted or that the company will regain compliance.

Risks

• Potential delisting of common stock from The Nasdaq Capital Market, leading to reduced liquidity and investor interest.
• Inability to regain compliance with Nasdaq's listing standards.
• Negative impact on the company's reputation and ability to raise capital.
• Further decline in stock price due to delisting concerns.

Future Outlook

The company intends to request a hearing before Nasdaq's Hearings Panel by November 20, 2025, which will stay the delisting action. However, there is no guarantee that the Panel will grant the request for continued listing or that the company will be able to regain and maintain compliance with Nasdaq's listing standards.

Management Comments

• The Company intends to request a hearing before the prescribed date, which request will stay any further suspension or delisting action by Nasdaq pending the ultimate conclusion of the hearing process.

Industry Context

This announcement is specific to Inspire Veterinary Partners, Inc.'s compliance with exchange listing rules and does not directly reflect broader industry trends in the veterinary services sector. However, delisting can impact a company's ability to compete for capital and talent within its industry.

Stakeholder Impact

• Shareholders: Potential loss of liquidity, reduced market visibility, and negative impact on share value if delisted.
• Employees: Potential impact on stock-based compensation and overall company morale due to uncertainty.
• Creditors: May view the company as higher risk, potentially impacting future financing terms.

Next Steps

• Inspire Veterinary Partners, Inc. must request a hearing before Nasdaq's Hearings Panel by November 20, 2025.
• The company will await the outcome of the Nasdaq hearing process regarding its continued listing.
• The company needs to address the underlying issues causing the low bid price to regain and maintain compliance, if granted continued listing.

Key Dates

Recommendation

The company faces imminent delisting from Nasdaq, a major exchange, due to persistent non-compliance with minimum bid price rules and a history of reverse stock splits that preclude a standard compliance period. While an appeal is planned, there is no assurance of success. Delisting would severely impair stock liquidity, market visibility, and investor confidence, likely leading to a significant decline in share value. This situation presents a high and immediate risk to investors.

Keywords

Inspire Veterinary Partners, IVP, Nasdaq, delisting, minimum bid price, reverse stock split, non-compliance, stock market, veterinary services